- February 02, 2023 09:15 AM EST
- February 01, 2023 08:36 AM EST
Medicure Announces Resignation Of Board Member And Grant Of Stock Options
- February 01, 2023 07:17 AM EST | Reuters
Feb 1 (Reuters) - Medicure Inc: * MEDICURE ANNOUNCES RESIGNATION OF BOARD MEMBER AND GRANT OF STOCK OPTIONS Source text for Eikon: Further company coverage:Read More...
Numinus Receives Clinical Trial Application Approval From Health Canada
- February 01, 2023 07:11 AM EST | Reuters
Feb 1 (Reuters) - Numinus Wellness Inc: * NUMINUS RECEIVES CLINICAL TRIAL APPLICATION APPROVAL FROM HEALTH CANADA FOR EXPERIENTIAL PSYCHEDELIC-ASSISTED THERAPY TRAINING USING PSILOCYBE CUBENSIS TEARead More...
Recruiting Underway In Fsd Pharma's Phase 2 Trial Of Fsd-Pea For Treatment Of Chronic Pain Associated With Idiopathic Mcas
- January 30, 2023 08:59 AM EST | Reuters
Jan 30 (Reuters) - FSD Pharma Inc: * RECRUITING UNDERWAY IN FSD PHARMA’S PHASE 2 TRIAL OF FSD-PEA (FSD201) FOR THE TREATMENT OF CHRONIC PAIN ASSOCIATED WITH IDIOPATHIC MCAS (MCAD) Source text forRead More...
ESSA Pharma Inc expected to post a loss of 23 cents a share - Earnings Preview
- January 30, 2023 07:43 AM EST | Reuters
* ESSA Pharma Inc is expected to show no change in quarterly revenue when it reports results on February 1 (estimated). * * Refinitiv's mean analyst estimate for ESSA Pharma Inc is for a loss of 23Read More...
ESSA Pharma Inc <EPIX.O>: A loss of 23 cents per share anticipated for fourth quarter
- January 30, 2023 07:42 AM EST | Reuters
30 January 2023 12:42 p.m. All figures in US dollars. ESSA Pharma Inc is expected to show a decrease in its fourth quarter earnings to -23 cents per share according to the mean Refinitiv estimateRead More...
Microbix Launches QAP To Support “Monkeypox” Testing
- January 30, 2023 07:40 AM EST | Reuters
Jan 30 (Reuters) - Microbix Biosystems Inc: * MICROBIX LAUNCHES QAP TO SUPPORT “MONKEYPOX” TESTING Source text for Eikon: Further company coverage:Read More...
Aptose Starts Dosing Of Tuspetinib In Patients With Acute Myeloid Leukemia
- January 30, 2023 07:30 AM EST | Reuters
Jan 30 (Reuters) - Aptose Biosciences Inc: * APTOSE INITIATES DOSING OF TUSPETINIB IN APTIVATE EXPANSION TRIAL IN PATIENTS WITH ACUTE MYELOID LEUKEMIA * APTOSE BIOSCIENCES INC-ANOTHER CLINICALRead More...
High Tide Inc expected to post a loss of 8 cents a share - Earnings Preview
- January 27, 2023 05:28 PM EST | Reuters
* High Tide Inc is expected to show a rise in quarterly revenue when it reports results on January 30. * The Calgary Alberta-based company is expected to report a 87.3% increase in revenue to C$100.9Read More...
XORTX Therapeutics Files For Mixed Shelf Of Up To $50 Mln
- January 27, 2023 07:01 AM EST | Reuters
Jan 27 (Reuters) - XORTX Therapeutics Inc: * XORTX THERAPEUTICS INC FILES FOR MIXED SHELF OF UP TO $50 MILLION – SEC FILING Further company coverage:Read More...